Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 33 | $58,108,759 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
04 Sep 2024 16:05 | SWTX | SpringWorks Therapeutics Inc | ISLAM SAQIB | Chief Executive Officer | 03 Sep 2024 | Sale | 6,692 | 42.0726 | 281,550 | D |
04 Sep 2024 16:05 | SWTX | SpringWorks Therapeutics Inc | ISLAM SAQIB | Chief Executive Officer | 03 Sep 2024 | Sale | 9,908 | 41.1041 | 407,259 | D |
04 Sep 2024 16:05 | SWTX | SpringWorks Therapeutics Inc | ISLAM SAQIB | Chief Executive Officer | 03 Sep 2024 | Sale | 32,400 | 40.0995 | 1,299,224 | D |
04 Sep 2024 16:05 | SWTX | SpringWorks Therapeutics Inc | EDRIS BADREDDIN | Chief Operating Officer | 03 Sep 2024 | Sale | 3,080 | 42.075 | 129,591 | D |
04 Sep 2024 16:05 | SWTX | SpringWorks Therapeutics Inc | EDRIS BADREDDIN | Chief Operating Officer | 03 Sep 2024 | Sale | 4,620 | 41.1158 | 189,955 | D |
04 Sep 2024 16:05 | SWTX | SpringWorks Therapeutics Inc | EDRIS BADREDDIN | Chief Operating Officer | 03 Sep 2024 | Sale | 12,300 | 40.1145 | 493,408 | D |
05 Jun 2024 16:08 | SWTX | SpringWorks Therapeutics Inc | ISLAM SAQIB | Chief Executive Officer | 03 Jun 2024 | Sale | 400 | 42.0925 | 16,837 | D |
05 Jun 2024 16:08 | SWTX | SpringWorks Therapeutics Inc | ISLAM SAQIB | Chief Executive Officer | 03 Jun 2024 | Sale | 6,600 | 41.401 | 273,247 | D |
05 Jun 2024 16:08 | SWTX | SpringWorks Therapeutics Inc | ISLAM SAQIB | Chief Executive Officer | 03 Jun 2024 | Sale | 8,760 | 40.5666 | 355,363 | D |
05 Jun 2024 16:08 | SWTX | SpringWorks Therapeutics Inc | ISLAM SAQIB | Chief Executive Officer | 03 Jun 2024 | Sale | 33,240 | 39.4003 | 1,309,666 | D |
05 Jun 2024 16:08 | SWTX | SpringWorks Therapeutics Inc | HAMBLETON JULIE | Director | 03 Jun 2024 | Sale | 20 | 42.0905 | 842 | D |
05 Jun 2024 16:08 | SWTX | SpringWorks Therapeutics Inc | HAMBLETON JULIE | Director | 03 Jun 2024 | Sale | 931 | 41.4924 | 38,629 | D |
05 Jun 2024 16:08 | SWTX | SpringWorks Therapeutics Inc | HAMBLETON JULIE | Director | 03 Jun 2024 | Sale | 751 | 40.5665 | 30,465 | D |
05 Jun 2024 16:08 | SWTX | SpringWorks Therapeutics Inc | HAMBLETON JULIE | Director | 03 Jun 2024 | Sale | 2,946 | 39.4132 | 116,111 | D |
05 Jun 2024 16:07 | SWTX | SpringWorks Therapeutics Inc | EDRIS BADREDDIN | Chief Operating Officer | 03 Jun 2024 | Sale | 385 | 42.0366 | 16,184 | D |
05 Jun 2024 16:07 | SWTX | SpringWorks Therapeutics Inc | EDRIS BADREDDIN | Chief Operating Officer | 03 Jun 2024 | Sale | 3,651 | 41.3767 | 151,066 | D |
05 Jun 2024 16:07 | SWTX | SpringWorks Therapeutics Inc | EDRIS BADREDDIN | Chief Operating Officer | 03 Jun 2024 | Sale | 4,192 | 40.6219 | 170,287 | D |
05 Jun 2024 16:07 | SWTX | SpringWorks Therapeutics Inc | EDRIS BADREDDIN | Chief Operating Officer | 03 Jun 2024 | Sale | 11,772 | 39.4015 | 463,834 | D |
20 Feb 2024 18:56 | SWTX | SpringWorks Therapeutics Inc | PICHL DANIEL | Chief People Officer | 16 Feb 2024 | Sale | 15,000 | 50.1033 | 751,550 | D |
05 Feb 2024 21:24 | SWTX | SpringWorks Therapeutics Inc | ASHAR BHAVESH | Chief Commercial Officer | 05 Feb 2024 | Sale | 4,834 | 49.3245 | 238,435 | D |
05 Feb 2024 21:24 | SWTX | SpringWorks Therapeutics Inc | ASHAR BHAVESH | Chief Commercial Officer | 02 Feb 2024 | Sale | 88 | 46.3733 | 4,081 | D |
05 Feb 2024 21:24 | SWTX | SpringWorks Therapeutics Inc | ASHAR BHAVESH | Chief Commercial Officer | 02 Feb 2024 | Sale | 378 | 45.9979 | 17,387 | D |
05 Feb 2024 21:24 | SWTX | SpringWorks Therapeutics Inc | ASHAR BHAVESH | Chief Commercial Officer | 02 Feb 2024 | Sale | 1,667 | 44.3119 | 73,868 | D |
05 Feb 2024 21:24 | SWTX | SpringWorks Therapeutics Inc | ASHAR BHAVESH | Chief Commercial Officer | 02 Feb 2024 | Sale | 1,089 | 43.7465 | 47,640 | D |
05 Feb 2024 21:23 | SWTX | SpringWorks Therapeutics Inc | PICHL DANIEL | Chief People Officer | 02 Feb 2024 | Sale | 743 | 46.4429 | 34,507 | D |
05 Feb 2024 21:23 | SWTX | SpringWorks Therapeutics Inc | PICHL DANIEL | Chief People Officer | 02 Feb 2024 | Sale | 1,997 | 45.9471 | 91,756 | D |
05 Feb 2024 21:23 | SWTX | SpringWorks Therapeutics Inc | PICHL DANIEL | Chief People Officer | 02 Feb 2024 | Sale | 9,266 | 43.8098 | 405,942 | D |
05 Feb 2024 21:23 | SWTX | SpringWorks Therapeutics Inc | PICHL DANIEL | Chief People Officer | 02 Feb 2024 | Sale | 14,175 | 44.3144 | 628,157 | D |
21 Jul 2023 16:13 | SWTX | SpringWorks Therapeutics Inc | HAMBLETON JULIE | Director | 19 Jul 2023 | Sale | 2,418 | 29.3118 | 70,876 | D |
22 Jun 2023 16:06 | SWTX | SpringWorks Therapeutics Inc | HAMBLETON JULIE | Director | 20 Jun 2023 | Sale | 2,400 | 26.918 | 64,603 | D |
20 Mar 2023 17:00 | SWTX | SpringWorks Therapeutics Inc | SCHWARTZ JEFFREY LAWRENCE | Director | 16 Mar 2023 | Sale | 1,750,000 | 28.5 | 49,875,000 | I |
16 Mar 2023 16:31 | SWTX | SpringWorks Therapeutics Inc | HAMBLETON JULIE | Director | 15 Mar 2023 | Sale | 1,106 | 31.5021 | 34,841 | D |
27 Jan 2023 16:30 | SWTX | SpringWorks Therapeutics Inc | PICHL DANIEL | Chief People Officer | 26 Jan 2023 | Sale | 858 | 31 | 26,598 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)